Engrail Therapeutics’ US$32 Million Extension Of Its Series A Financing

Martina Bellini North America, North America Legal Chronicle
Tagged:

Hogan Lovells Engrail Therapeutics on the deal.Engrail Therapeutics recently completed US$32 million extension of its Series A financing round, bringing the total to US$64 million for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here